AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
New Fortress Energy
NFE
Cars.com
CARS
Halozyme Therapeutics
HALO
Collegium Pharmaceutical
COLL
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 589.09%18.03M | 12.21%7.45M | 452.45%11.36M | -95.84%-5.32M | 203.28%4.54M | 86.45%-3.69M | 197.62%6.64M | -222.60%-3.22M | 59.86%-2.71M | 73.01%-4.39M |
Net income from continuing operations | 106.17%2.35M | ---- | ---- | ---- | ---- | -1,057.76%-38.12M | ---- | ---- | ---- | ---- |
Operating gains losses | -74.81%-11.43M | ---- | ---- | ---- | ---- | 29.63%-6.54M | ---- | ---- | ---- | ---- |
Depreciation and amortization | 5.30%18.61M | ---- | ---- | ---- | ---- | 1.53%17.67M | ---- | ---- | ---- | ---- |
Deferred tax | 108.74%259K | ---- | ---- | ---- | ---- | -733.33%-2.96M | ---- | ---- | ---- | ---- |
Other non cash items | -105.77%-2.4M | ---- | ---- | ---- | ---- | 1,510.86%41.69M | ---- | ---- | ---- | ---- |
Change In working capital | 150.91%8.91M | ---- | ---- | ---- | ---- | 51.72%-17.51M | ---- | ---- | ---- | ---- |
-Change in receivables | 157.32%20.04M | ---- | ---- | ---- | ---- | 948.15%7.79M | ---- | ---- | ---- | ---- |
-Change in inventory | 439.90%4.76M | ---- | ---- | ---- | ---- | 92.17%-1.4M | ---- | ---- | ---- | ---- |
-Change in payables and accrued expense | 1,229.62%8.92M | ---- | ---- | ---- | ---- | -114.50%-790K | ---- | ---- | ---- | ---- |
-Change in other current assets | -1,247.70%-3.25M | ---- | ---- | ---- | ---- | 107.18%283K | ---- | ---- | ---- | ---- |
-Change in other current liabilities | 7.82%-21.56M | ---- | ---- | ---- | ---- | -23.42%-23.39M | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 589.09%18.03M | 12.21%7.45M | 452.45%11.36M | -95.84%-5.32M | 203.28%4.54M | 86.45%-3.69M | 197.62%6.64M | -222.60%-3.22M | 59.86%-2.71M | 73.01%-4.39M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 58.12%-8.25M | 74.26%-1.59M | 42.17%-2.29M | 75.42%-1.53M | 15.25%-2.85M | -20.71%-19.69M | -62.71%-6.17M | 31.70%-3.96M | -82.71%-6.2M | -0.81%-3.36M |
Net PPE purchase and sale | 40.04%-12.18M | 40.59%-3.75M | 28.97%-2.93M | 58.19%-2.66M | 19.13%-2.84M | -21.89%-20.32M | -72.00%-6.31M | 32.72%-4.13M | -84.13%-6.37M | -3.06%-3.51M |
Net investment purchase and sale | 0.47%638K | 7.64%155K | -7.47%161K | 98.80%330K | -105.30%-8K | 74.45%635K | 220.00%144K | -49.71%174K | 159.38%166K | 104.05%151K |
Net other investing changes | --3.3M | --2.01M | --485K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 58.12%-8.25M | 74.26%-1.59M | 42.17%-2.29M | 75.42%-1.53M | 15.25%-2.85M | -20.71%-19.69M | -62.71%-6.17M | 31.70%-3.96M | -82.71%-6.2M | -0.81%-3.36M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -106.24%-1.35M | -623.29%-1.91M | -236.90%-5.37M | -68.61%3.89M | -59.42%2.03M | -49.07%21.69M | -94.54%365K | -53.39%3.92M | 10.06%12.41M | -69.20%5M |
Net issuance payments of debt | -112.47%-1.42M | 55.44%-1.4M | -425.54%-4.25M | -73.14%2.2M | -59.42%2.03M | -68.75%11.36M | -172.36%-3.14M | -71.01%1.3M | -27.26%8.2M | -69.20%5M |
Net other financing activities | -99.39%63K | -114.51%-509K | -142.83%-1.12M | ---- | ---- | 70.73%10.33M | 63.90%3.51M | --2.62M | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -106.24%-1.35M | -623.29%-1.91M | -236.90%-5.37M | -68.61%3.89M | -59.42%2.03M | -49.07%21.69M | -94.54%365K | -53.39%3.92M | 10.06%12.41M | -69.20%5M |
Net cash flow | ||||||||||
Beginning cash position | -16.59%7.29M | 95.12%11.84M | -16.71%7.89M | 78.28%10.83M | -16.59%7.29M | -15.50%8.74M | -50.21%6.07M | 28.53%9.48M | -10.48%6.07M | -15.50%8.74M |
Current changes in cash | 600.89%8.43M | 372.97%3.95M | 213.69%3.7M | -184.44%-2.95M | 235.20%3.72M | -81.16%-1.68M | 121.35%836K | -162.12%-3.26M | 212.63%3.49M | 18.49%-2.75M |
Effect of exchange rate changes | -223.50%-289K | -197.63%-371K | 268.71%248K | 110.23%9K | -296.63%-175K | 134.77%234K | -17.57%380K | 65.57%-147K | 83.36%-88K | 150.00%89K |
End cash Position | 111.73%15.43M | 111.73%15.43M | 95.12%11.84M | -16.71%7.89M | 78.28%10.83M | -16.59%7.29M | -16.59%7.29M | -50.21%6.07M | 28.53%9.48M | -10.48%6.07M |
Free cash flow | 124.17%5.83M | 1,031.80%3.7M | 214.58%8.42M | 12.06%-7.99M | 121.15%1.7M | 45.02%-24.13M | 103.12%327K | -109.73%-7.35M | 11.16%-9.08M | 59.21%-8.03M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |